Page last updated: 2024-09-04

docetaxel anhydrous and adenosine

docetaxel anhydrous has been researched along with adenosine in 4 studies

Compound Research Comparison

Studies
(docetaxel anhydrous)
Trials
(docetaxel anhydrous)
Recent Studies (post-2010)
(docetaxel anhydrous)
Studies
(adenosine)
Trials
(adenosine)
Recent Studies (post-2010) (adenosine)
12,1103,2166,92032,5361,0758,930

Protein Interaction Comparison

ProteinTaxonomydocetaxel anhydrous (IC50)adenosine (IC50)
high affinity choline transporter 1 isoform aHomo sapiens (human)0.3851
Sodium/nucleoside cotransporter 1Homo sapiens (human)5.5
Sodium/nucleoside cotransporter 2Homo sapiens (human)5.5
Adenosine receptor A3Homo sapiens (human)0.0011
Adenosine receptor A1Homo sapiens (human)0.0023
Equilibrative nucleoside transporter 1Homo sapiens (human)63
Solute carrier family 28 member 3Homo sapiens (human)3.3

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Jeengar, MK; Khan, W; Naidu, VG; Singh, I; Sistla, R; Swami, R1
Li, H; Li, X; Lv, M; Qiao, B1
Gu, HY; Hu, C; Huang, ZD; Lin, LL; Liu, ZZ; Wei, RX1

Reviews

1 review(s) available for docetaxel anhydrous and adenosine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for docetaxel anhydrous and adenosine

ArticleYear
Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting.
    International journal of pharmaceutics, 2015, Volume: 486, Issue:1-2

    Topics: Adenosine; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Docetaxel; Humans; Lipids; Mice; Nanoparticles; Neoplasms; Taxoids

2015
Blockade pf CD73/adenosine axis improves the therapeutic efficacy of docetaxel in epithelial ovarian cancer.
    Archives of gynecology and obstetrics, 2019, Volume: 299, Issue:6

    Topics: Adenosine; Animals; Antigens, Neoplasm; Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Disease Models, Animal; Docetaxel; Female; Humans; Mice; Tetraspanins

2019
m6A Modification Patterns With Distinct Immunity, Metabolism, and Stemness Characteristics in Soft Tissue Sarcoma.
    Frontiers in immunology, 2021, Volume: 12

    Topics: Adenosine; Antineoplastic Agents; Deoxycytidine; DNA Copy Number Variations; DNA Methylation; Docetaxel; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Kaplan-Meier Estimate; Sarcoma

2021
chemdatabank.com